Search results for "kinetics"

showing 10 items of 2224 documents

Efecto de la administración concomitante de indometacina o ibuprofeno en la farmacocinética de amikacina en neonatos prematuros

2006

Objective: To evaluate whether the concomitant administration of ibuprofen or indomethacin plus amikacin may alter the latter drug's pharmacokinetic parameters, and hence amikacin plasma levels. Method: Retrospective cohort study performed by reviewing the medical records of premature children with persistent ductus arteriosus receiving amikacin and ibuprofen, or amikacin and indomethacin. They were divided up into three groups: group 1: treatment with amikacin went before indomethacin or ibuprofen; group 2: simultaneously treated with amikacin and indomethacin; group 3: simultaneously treated with amikacin and ibuprofen. Pharmacokinetic parameters, distribution volume, and amikacin clearan…

Pharmacologybusiness.industryorganic chemicalsRetrospective cohort studyPlasma levelsbiochemical phenomena metabolism and nutritionIbuprofencarbohydrates (lipids)PharmacokineticsPersistent ductus arteriosusAmikacinAnesthesiaConcomitantotorhinolaryngologic diseasespolycyclic compoundsmedicinebusinessmedicine.drugFarmacia Hospitalaria
researchProduct

Purification of a nuclease from human serum.

1981

The purification procedure for a nuclease from human serum is described. It includes ammonium sulfate precipitation, chromatography on DEAE-Sephadex and on Sephacryl-S 200, and preparative electrophoresis. The enzyme, purified about 2000-fold, is homogeneous in a sodium dodecyl sulfate electrophoretic system, where it has a mol. wt of 78,000. The pH optimum lies around pH 6.5; it is a sugar-nonspecific endonuclease.

Pharmacologychemistry.chemical_classificationNucleaseChromatographyDeoxyribonucleasesbiologyCell BiologyCellular and Molecular NeuroscienceElectrophoresischemistry.chemical_compoundEndonucleaseKineticsEnzymechemistrybiology.proteinMolecular MedicineHumansAmmoniumSodium dodecyl sulfateSulfateMolecular BiologyAmmonium sulfate precipitationExperientia
researchProduct

A 18F-labeled dibenzocyclooctyne (DBCO) derivative for copper-free click labeling of biomolecules

2016

The new prosthetic group 18F-TEG-DBCO (dibenzocyclooctyne) can be prepared within a total reaction time of 60 min including purification with an overall yield (n.d.c.) of 34 ± 5%. Copper-free click cycloadditions with an azido-cRGD, a folate-azide and two α-MSH analogue azido-peptides resulted in very high RCYs and fast reaction kinetics.

Pharmacologychemistry.chemical_classificationbiology010405 organic chemistryBiomoleculeOrganic ChemistryPharmaceutical Sciencechemistry.chemical_element010402 general chemistry01 natural sciencesBiochemistryCombinatorial chemistryCopperCofactor0104 chemical sciencesChemical kineticschemistry.chemical_compoundchemistryYield (chemistry)Drug Discoverybiology.proteinMolecular MedicineDerivative (chemistry)MedChemComm
researchProduct

Increased bioavailability of oral melatonin after fluvoxamine coadministration*1

2000

Background Fluvoxamine, a selective serotonin reuptake inhibitor, is known to elevate melatonin serum concentrations. It has not been clear whether these effects might be attributed to an increased melatonin production or to an decreased elimination of melatonin. The latter hypothesis was tested by this study. Methods Five healthy male volunteers (one CYP2D6 poor metabolizer) received 5 mg melatonin either with or without coadministration of 50 mg fluvoxamine. Serum concentrations of melatonin and fluvoxamine were assessed from 0 to 28 hours after melatonin intake. Results Coadministration of fluvoxamine, on average, led to an 17-fold higher (P <.05) area under concentration–time curve (AUC…

Pharmacologyendocrine systemmedicine.medical_specialtybusiness.industrySerotonin reuptake inhibitorCmaxFluvoxaminePharmacologyBioavailabilityMelatoninEndocrinologyPharmacokineticsOral administrationInternal medicinemedicinePharmacology (medical)Reuptake inhibitorbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugClinical Pharmacology &amp; Therapeutics
researchProduct

Rewarding Properties of Testosterone in Intact Male Mice

2000

The present study examined the rewarding properties of 4-androsten-17β-ol-3-one testosterone in intact male mice using the conditioned place preference (CPP) technique. In Experiment 1, the pharmacokinetics of 0.8 and 1.2 mg/kg of testosterone were studied to determine the most appropriate temporal interval to test behavior. Additionally, the locomotor activity was recorded to control a possible interfering effect on CPP. The maximum testosterone concentration was registered at 45 min of administration, and no effects on activity were found. In Experiment 2, three groups of male OF-1 mice received four pairings of the least-preferred compartment with testosterone (0.8, 1, or 1.2 mg/kg, SC) …

Pharmacologymedicine.medical_specialtyChemistrymedicine.drug_classRatónClinical BiochemistryTestosterone (patch)ToxicologyAndrogenBiochemistryConditioned place preferenceBehavioral NeuroscienceEndocrinologyPharmacokineticsInternal medicineBlood plasmamedicineCompartment (pharmacokinetics)Intact maleBiological PsychiatryPharmacology Biochemistry and Behavior
researchProduct

Farmacocinética del metronidazol y la gentamicina en dosis única preoperatoria para profilaxis antibiótica quirúrgica en cirugía colorrectal

2008

Objective: To describe, in patients undergoing colorectal surgery (CRS), the pharmacokinetics of a single, prophylactic preoperative dose of 1,500 mg of metronidazole plus 240 mg gentamicin and measure its efficacy in accordance with the accepted pharmacodynamic and microbiological parameters. Method: Thirty-six patients undergoing CRS agreed to participate in the study. Three blood samples were taken from each. Cmax 15 minutes after finishing the infusion of the mixture, CfinIQ on finishing the surgery, and Cmin between 12 and 24 hours post-administration. The concentrations of metronidazole and gentamicin in each simple were measured and the pharmacokinetic parameters were estimated (dV- …

Pharmacologymedicine.medical_specialtybusiness.industryUrologyCmaxCminMetronidazolePharmacokineticsPharmacodynamicsAnesthesiamedicineGentamicinIn patientClinical efficacybusinessmedicine.drugFarmacia Hospitalaria
researchProduct

Monitorización de la vacomicina en administración intraperitoneal en pacientes sometidos a diálisis peritoneal continua ambulatoria

2012

Objective: To validate a pharmacokinetic model of the treatments with intraperitoneal vancomycin applied to patients on continuous ambulatory peritoneal dialysis with bacterial peritonitis. Methods: To carry out a prospective study divided in 2 cohorts: the first one including ten patients of 56 ± 14 years and 65 ± 5 kg, and the second one with 10 patients (12 episodes of peritonitis) aged 52 ± 13 years and 64 ± 8 kg. The treatment consists of administering and retaining for 6 h in the peritoneal cavity a solution containing 2 g of vancomycin and 1 g of ceftazidime into 2 l of ‘‘dialysis solution’’. After the antibiotic administration, blood samples were obtained at 4, 6, 8, 10, 24, 48 and …

Pharmacologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentContinuous ambulatory peritoneal dialysisUrologyPeritonitismedicine.diseasePeritoneal dialysisPharmacokineticsCohortmedicineVancomycinProspective cohort studybusinessmedicine.drugCohort studyFarmacia Hospitalaria
researchProduct

Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence

2018

Aims: Previously, we have reported an association between clozapine use and elevated FL3 neutrophil fluorescence, a flow-cytometric parameter for cell viability. Here, we developed and evaluated a pharmacokinetic-pharmacodynamic model relating FL3-fluorescence to clozapine exposure and derived a nomogram for estimation of long-term adherence. Methods: Data from 27 patients initiating clozapine were analysed using nonlinear mixed effects modelling. A previously described pharmacokinetic model for clozapine was coupled to a FL3 fluorescence model. For this, an effect compartment with clozapine concentrations as input and a first order decay rate as output was linked with an Emax model to FL3-…

Pharmacologymedicine.medical_specialtygenetic structuresbusiness.industryCoefficient of variationUrologyDrug holidayNomogramurologic and male genital diseases030226 pharmacology & pharmacy030227 psychiatry03 medical and health sciences0302 clinical medicinePharmacokineticsPharmacodynamicsmedicineBiomarker (medicine)Pharmacology (medical)Clozapine therapybusinessClozapinemedicine.drugBritish Journal of Clinical Pharmacology
researchProduct

Dehydration of mildronate dihydrate: a study of structural transformations and kinetics

2014

The dehydration of mildronate dihydrate (3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propionate dihydrate) was investigated by powder X-ray diffraction, thermal analysis, hot-stage microscopy, water sorption–desorption studies and dehydration kinetic studies. It was determined that mildronate dihydrate dehydrated in a single step, directly transforming into the anhydrous form. In order to understand the reasons for a one step dehydration mechanism, crystal structures of dihydrate, monohydrate and anhydrous forms were compared, proving the similarity of the dihydrate and anhydrous forms. In order to understand the reasons for molecule reorganization during dehydration, the energy of the anhydrous …

Phase boundaryChemistryInorganic chemistryKineticsGeneral ChemistryCrystal structureCondensed Matter Physicsmedicine.diseaseRate-determining stepPhase (matter)medicineAnhydrousPhysical chemistryGeneral Materials ScienceDehydrationThermal analysisCrystEngComm
researchProduct

Crystal growth kinetics in deionised two-component colloidal suspensions

2007

We report first measurements of the crystal growth velocity in deionised two-component aqueous suspensions of charged polystyrene latex spheres. The size ratio was 1:1.3 and mixing ratios up to 18% of the larger particle were investigated. For the pure components limiting growth velocities of (V ∞,120 = 4.8 µm s−1 and V ∞,156 = 2.9 µm s−1) were observed. In the mixture v drops with increasing mixing ratio even below (V ∞,156) of the large minority component. Careful monitoring of the deionisation procedure excludes the explanation of enhanced ionic contamination. Alternatives based on the kinetics of particle attachment and the position of the phase boundary are discussed.

Phase boundaryColloidAqueous solutionChemistryKineticsPolymer chemistryMixing (process engineering)Analytical chemistryParticleCrystal growthCharged particle
researchProduct